Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $25.64M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −53.9% to +107.0% across the middle 80 percent of the group, with a median of −27.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $54.52M | Micro cap | +6.62% |
| ABDX.L | Abingdon Health Plc | $37.08M | Micro cap | +100.00% |
| RENX.L | Renalytix Plc | $25.64M | Micro cap | −27.35% |
| GSS.AX | Genetic Signatures Limited | $13.51M | Micro cap | −72.33% |
| CNSL.L | Cambridge Nutritional Sciences plc | $6.17M | Micro cap | −41.54% |
| BIAF | bioAffinity Technologies, Inc. | $3.14M | Micro cap | −30.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.